Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
QMRO Home
Blizard Institute
Centre for Genomics and Child Health
RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
QMRO Home
Blizard Institute
Centre for Genomics and Child Health
RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
View/
Open
Accepted version (21.63Mb)
Publisher
Springer Nature [academic journals on nature.com]
Journal
Oncogene
ISSN
0950-9232
Metadata
Show full item record
Authors
Koschut, D; Ray, D; Li, Z; Emanuela, G; Groet, J; Ivan, A; Kham, SK-Y; Chng, WJ; Ariffin, H; Weinstock, DM
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/68389
Collections
Centre for Genomics and Child Health
[831]
Licence information
CC BY